Study of Some Biochemical Parameters in Patients with Type 2 Diabetes Mellitus as an Early Detection of Diabetic Nephropathy in Al-Ramadi City
DOI:
https://doi.org/10.31185/wjps.341Keywords:
T2DM, Diabetic nephropathy, HbA1CAbstract
Diabetes is a persistent medical disease that is rapidly spreading globally, and one of its most severe outcomes is diabetic nephropathy. Various markers may be used to detect renal disease at an early stage, which, if not treated, progresses to kidney failure, and often leads to death. The present research aims to detect early signs of diabetic nephropathy by comparing renal function decline in patients with type 2 diabetes mellitus to that of healthy individuals without diabetes in Al-Ramadi City. This research included a total of 80 blood samples, which were categorized into two distinct groups. Fifty samples were obtained from patients diagnosed with Type 2 Diabetes Mellitus (T2DM) who were recruited from a private clinic, while the remaining thirty samples were collected from individuals who were deemed to be in good condition and served as normal healthy controls. All participants had comprehensive history collection, meticulous clinical examination, and standard laboratory tests, which included fasting blood sugar, hemoglobin A1c, urea, and creatinine. The fasting blood sugar and HbA1c levels in the blood, as well as the levels of urea and creatinine in the serum, exhibited a substantial rise (P<0.001) in patients with type II diabetes mellitus compared to the control group. The diagnosis of renal failure arising from complications of T2DM might rely on examinations of FBS, HbA1C, Urea, and Creatinine as reliable prognostic indications.
References
Thipsawat, S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diabetes and Vascular Disease Research, 18(6), 14791641211058856, 2021.
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., ... & IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice, 157, 107843, 2019.
. Balaji, R., Duraisamy, R., & Kumar, M. P. Complications of diabetes mellitus: A review. Drug Invention Today, 12(1), 2019.
. Kurniawan, M. R., & Kusrini, E. Ureum and Creatinine Health Study in Patients Diabetes Mellitus. Indonesian Journal of Medical Laboratory Science and Technology, 2(2), 85-92, 2020.
Selby, N. M., & Taal, M. W. An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes, Obesity and Metabolism, 22, 3-15, 2020.
AbuMustafa, A. M. clinical and Biochemical associations with Diabetic retinopathy in Male Patients in the gaza strip. Frontiers in endocrinology, 8, 302, 2017.
Shrestha, S., Gyawali, P., Shrestha, R., Poudel, B., & Sigdel, M. Serum urea and creatinine in diabetic and non-diabetic subjects. Journal of Nepal Association for Medical Laboratory Sciences P, 9(1), 11-12, 2008.
Trinder, P. Quantitative determination of glucose using GOD-PAP method Ann. Clin Biochem, 6, 24-27, 1969.
Bowers, L. D. Kinetic serum creatinine assays I. The role of various factors in determining specificity. Clinical Chemistry, 26(5), 551-554, 1980.
Richterich, R., & Küffer, H. Die bestimmung des harnstoffs in plasma und serum (Urease/BERTHELOT-Methode) mit dem greiner electronic selective analyzer GSA II, 1973.
Sai R, Sankeerthi C, Sandhya R, Rajkumar G and Aravind V A study on evaluating blood urea and serum creatinine in diabetes mellitus patients. International Journal of Clinical Biochemistry and Research;8(4):285–288. 2021
Bamanikar, S. A., Bamanikar, A. A., & Arora, A. Study of Serum urea and Creatinine in Diabetic and nondiabetic patients in a tertiary teaching hospital. The Journal of Medical Research, 2(1), 12-15, 2016.
Al, H. A. A. E. F. The Relationship between Some Biochemical Parameters and Type 2 Diabetes Mellitus among Iraqi Patients. Iraqi journal of biotechnology, 21(2), 2022.
Qais, A. N. (2020, September). Estimation of Urea and Creatinine in Type 2 Diabetes Mellitus Patients. In IMDC-SDSP 2020: Proceedings of the 1st International Multi-Disciplinary Conference Theme: Sustainable Development and Smart Planning, IMDC-SDSP 2020, Cyperspace, 28-30 June 202 (p. 175). European Alliance for Innovation.
Bagalad, B. S., Mohankumar, K. P., Madhushankari, G. S., Donoghue, M., & Kuberappa, P. H. (2017). Diagnostic accuracy of salivary creatinine, urea, and potassium levels to assess dialysis need in renal failure patients. Dental research journal, 14(1), 13.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ateka Qaddoori, Nuha Khalaf

This work is licensed under a Creative Commons Attribution 4.0 International License.